Trust Investment Advisors Purchases New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Trust Investment Advisors purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 796 shares of the company’s stock, valued at approximately $242,000.

Other institutional investors have also recently added to or reduced their stakes in the company. BDO Wealth Advisors LLC grew its stake in HCA Healthcare by 60.0% in the 2nd quarter. BDO Wealth Advisors LLC now owns 160 shares of the company’s stock valued at $49,000 after acquiring an additional 60 shares during the period. Covestor Ltd raised its holdings in shares of HCA Healthcare by 122.7% during the 1st quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after acquiring an additional 92 shares during the period. WASHINGTON TRUST Co raised its holdings in HCA Healthcare by 100.0% in the 2nd quarter. WASHINGTON TRUST Co now owns 180 shares of the company’s stock valued at $55,000 after buying an additional 90 shares during the period. Scissortail Wealth Management LLC purchased a new stake in HCA Healthcare in the 1st quarter valued at about $315,475,000. Finally, Capital Advisors Ltd. LLC raised its holdings in HCA Healthcare by 895.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 199 shares of the company’s stock valued at $60,000 after buying an additional 179 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 2.5 %

HCA stock traded up $5.96 during trading on Friday, hitting $246.38. 3,050,140 shares of the company’s stock were exchanged, compared to its average volume of 1,313,774. The company has a current ratio of 1.15, a quick ratio of 0.99 and a debt-to-equity ratio of 103.06. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $304.86. The business has a 50-day moving average price of $242.32 and a two-hundred day moving average price of $266.50. The stock has a market capitalization of $65.95 billion, a price-to-earnings ratio of 12.12, a PEG ratio of 1.38 and a beta of 1.66.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $3.91 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($0.06). The firm had revenue of $16.21 billion during the quarter, compared to analyst estimates of $15.77 billion. HCA Healthcare had a net margin of 9.05% and a return on equity of 2,040.32%. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 18.18 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. Investors of record on Thursday, December 14th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.97%. The ex-dividend date is Wednesday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.81%.

Analyst Upgrades and Downgrades

HCA has been the topic of several research analyst reports. Sanford C. Bernstein reduced their price objective on shares of HCA Healthcare from $345.00 to $294.00 in a report on Tuesday, October 10th. Oppenheimer lifted their target price on HCA Healthcare from $310.00 to $315.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Mizuho dropped their target price on HCA Healthcare from $325.00 to $275.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Stephens reaffirmed an “overweight” rating and issued a $280.00 target price on shares of HCA Healthcare in a research report on Friday, November 10th. Finally, Raymond James dropped their target price on HCA Healthcare from $320.00 to $280.00 and set an “outperform” rating for the company in a research report on Wednesday, October 25th. Two equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $296.59.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.